| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.05 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.25 | 0.05 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |